New Results
MTX-COVAB, a human-derived antibody with potent neutralizing activity against SARS-CoV-2 infection in vitro and in a hamster model of COVID-19
Simone Schmitt, Marcel Weber, Matthias Hillenbrand, Jemima Seidenberg, Andreas Zingg, Catherine Townsend, Barbara Eicher, Justina Rutkauskaite, Peggy Riese, Carlos A. Guzman, Karsten Fischer, View ORCID ProfileChristoph Esslinger
doi: https://doi.org/10.1101/2020.12.01.406934
Simone Schmitt
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Marcel Weber
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Matthias Hillenbrand
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Jemima Seidenberg
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Andreas Zingg
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Catherine Townsend
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Barbara Eicher
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Justina Rutkauskaite
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Peggy Riese
3Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
Carlos A. Guzman
3Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
Karsten Fischer
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Christoph Esslinger
1Memo Therapeutics AG, Schlieren, Zurich, Switzerland
Article usage
Posted December 02, 2020.
MTX-COVAB, a human-derived antibody with potent neutralizing activity against SARS-CoV-2 infection in vitro and in a hamster model of COVID-19
Simone Schmitt, Marcel Weber, Matthias Hillenbrand, Jemima Seidenberg, Andreas Zingg, Catherine Townsend, Barbara Eicher, Justina Rutkauskaite, Peggy Riese, Carlos A. Guzman, Karsten Fischer, Christoph Esslinger
bioRxiv 2020.12.01.406934; doi: https://doi.org/10.1101/2020.12.01.406934
MTX-COVAB, a human-derived antibody with potent neutralizing activity against SARS-CoV-2 infection in vitro and in a hamster model of COVID-19
Simone Schmitt, Marcel Weber, Matthias Hillenbrand, Jemima Seidenberg, Andreas Zingg, Catherine Townsend, Barbara Eicher, Justina Rutkauskaite, Peggy Riese, Carlos A. Guzman, Karsten Fischer, Christoph Esslinger
bioRxiv 2020.12.01.406934; doi: https://doi.org/10.1101/2020.12.01.406934
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)